DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AZD-9496
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
AZD-9496
×
Maximum Phase:
1
First Approval:
None
UNII:
DA9P7LN909
Molecule Type:
Small molecule
Molecular Formula:
C25H25F3N2O2
Molecular Weight:
442.48
AlogP:
5.63
PSA:
56.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ADC-1013
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
ADC-1013
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HM-43239
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
HM-43239
×
Maximum Phase:
1
First Approval:
None
UNII:
C0WUS7XXE9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
LEMZOPARLIMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma
Unknown
LEMZOPARLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEXANERSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Huntington Disease
Unknown
LEXANERSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHI-101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PHI-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2S
Molecular Weight:
386.45
AlogP:
2.26
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
3.0
Source:
CROTEDUMAB
1
Antibody
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Glucagon receptor inhibitor
CROTEDUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
4JQ68PW6XF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NM-21-1480
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
NM-21-1480
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PGT-121
1
Unknown
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome; HIV Infections
Unknown
PGT-121
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4K58C6RT2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-811
1
Antibody
Investigational
Unknown
Unknown
Psoriasis
Interferon gamma inhibitor
AMG-811
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-00562271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Focal adhesion kinase 1 inhibitor
PF-00562271
×
Maximum Phase:
1
First Approval:
None
UNII:
K5BX8ZA7UF
Molecule Type:
Small molecule
Molecular Formula:
C21H20F3N7O3S
Molecular Weight:
507.5
AlogP:
3.14
PSA:
129.21
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DSTA-4637S
1
Unknown
Investigational
Unknown
Unknown
Bacteremia
Unknown
DSTA-4637S
×
Maximum Phase:
1
First Approval:
None
UNII:
BW3SSD8PZ3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-4573
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-4573
×
Maximum Phase:
1
First Approval:
None
UNII:
E5XSP3X68B
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClN5O2
Molecular Weight:
429.95
AlogP:
3.81
PSA:
88.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HUMAN RECOMBINANT BONE MORPHOGENETIC PROTEIN 4
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma
Unknown
HUMAN RECOMBINANT BONE MORPHOGENETIC PROTEIN 4
×
Maximum Phase:
1
First Approval:
None
UNII:
08RQ4CQ601
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONVATILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ONVATILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
1UI8F5IIZ4
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CDP-850
1
Antibody
Investigational
Unknown
Unknown
Unknown
Selectin E inhibitor
CDP-850
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NONA-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
PK7O6W0U44
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
PF-04620110
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Unknown
PF-04620110
×
Maximum Phase:
1
First Approval:
None
UNII:
CQ4M18RLJW
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O4
Molecular Weight:
396.45
AlogP:
2.85
PSA:
118.64
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUCARESOL
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TUCARESOL
×
Maximum Phase:
1
First Approval:
None
UNII:
JH368G5B9M
Molecule Type:
Small molecule
Molecular Formula:
C15H12O5
Molecular Weight:
272.26
AlogP:
2.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ONL1204
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ONL1204
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OSALMID
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
OSALMID
×
Maximum Phase:
1
First Approval:
None
UNII:
89741L759Z
Molecule Type:
Small molecule
Molecular Formula:
C13H11NO3
Molecular Weight:
229.24
AlogP:
2.35
PSA:
69.56
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
EXICORILANT
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
EXICORILANT
×
Maximum Phase:
1
First Approval:
None
UNII:
GTB859B7K8
Molecule Type:
Small molecule
Molecular Formula:
C26H23F4N7O3S
Molecular Weight:
589.58
AlogP:
3.23
PSA:
115.87
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MDC
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MDC
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
81
82
83
84
85
86
87
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA